ES2176698T3 - Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. - Google Patents
Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.Info
- Publication number
- ES2176698T3 ES2176698T3 ES97907141T ES97907141T ES2176698T3 ES 2176698 T3 ES2176698 T3 ES 2176698T3 ES 97907141 T ES97907141 T ES 97907141T ES 97907141 T ES97907141 T ES 97907141T ES 2176698 T3 ES2176698 T3 ES 2176698T3
- Authority
- ES
- Spain
- Prior art keywords
- erythromycin
- medicines
- application
- preparation procedure
- new derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I), EN LA CUAL: X REPRESENTA UN RADICAL CH 2 O SO 2 O UN ATOMO DE OXIGENO; Y REPRESENTA UN RADICAL (CH 2 ) M (CH = CH) N)(CH 2 ) O , CON M + N + O 8, N = 0 O 1; AR REPRESENTA UN RADICAL ARILO; Y W REPRESENTA UN ATOMO DE HIDROGENO O EL RESTO DE UNA FUNCION CARBAMATO. LOS COMPUESTOS DE FORMULA (I) PRESENTAN INTERESANTES PROPIEDADES ANTIBIOTICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9602472A FR2745290B1 (fr) | 1996-02-28 | 1996-02-28 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2176698T3 true ES2176698T3 (es) | 2002-12-01 |
Family
ID=9489659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97907141T Expired - Lifetime ES2176698T3 (es) | 1996-02-28 | 1997-02-27 | Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. |
Country Status (31)
Country | Link |
---|---|
US (1) | US6096714A (es) |
EP (1) | EP0885234B1 (es) |
JP (1) | JP4102440B2 (es) |
KR (1) | KR100486053B1 (es) |
CN (1) | CN1168734C (es) |
AP (1) | AP952A (es) |
AR (1) | AR005999A1 (es) |
AT (1) | ATE217633T1 (es) |
AU (1) | AU716204B2 (es) |
BG (1) | BG63207B1 (es) |
BR (1) | BR9707709B1 (es) |
CZ (1) | CZ293893B6 (es) |
DE (1) | DE69712610T2 (es) |
DK (1) | DK0885234T3 (es) |
EA (1) | EA001376B1 (es) |
EE (1) | EE9800265A (es) |
ES (1) | ES2176698T3 (es) |
FR (1) | FR2745290B1 (es) |
HU (1) | HU227567B1 (es) |
IL (1) | IL125622A (es) |
NO (1) | NO983955L (es) |
NZ (1) | NZ331600A (es) |
OA (1) | OA10845A (es) |
PL (1) | PL191736B1 (es) |
PT (1) | PT885234E (es) |
SK (1) | SK118498A3 (es) |
TR (1) | TR199801713T2 (es) |
UA (1) | UA58504C2 (es) |
WO (1) | WO1997031929A1 (es) |
YU (1) | YU37098A (es) |
ZA (1) | ZA971659B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA989830B (en) * | 1997-10-29 | 1999-05-04 | Taisho Pharmaceutical Co Ltd | Erythromycin a derivatives |
WO1999021869A1 (en) * | 1997-10-29 | 1999-05-06 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a, 11,12-carbamate derivatives |
JP4573925B2 (ja) * | 1998-07-09 | 2010-11-04 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用 |
FR2792637B1 (fr) * | 1999-04-26 | 2001-06-01 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2780977B1 (fr) * | 1998-07-09 | 2000-09-01 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2781484B1 (fr) * | 1998-07-21 | 2001-08-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
KR20020002380A (ko) | 1999-01-27 | 2002-01-09 | 실버스타인 아써 에이. | 케톨라이드 항생물질 |
AU3832100A (en) * | 1999-05-24 | 2000-12-12 | Pfizer Products Inc. | 13-methyl-erythromycin derivatives |
AU6316400A (en) * | 1999-08-06 | 2001-03-05 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
WO2001010878A1 (fr) * | 1999-08-06 | 2001-02-15 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
AU6183800A (en) * | 1999-08-06 | 2001-03-05 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
US20020115621A1 (en) * | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
ITMI20021726A1 (it) | 2002-08-01 | 2004-02-02 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
WO2004080391A2 (en) | 2003-03-10 | 2004-09-23 | Optimer Pharmaceuticals, Inc. | Novel antibacterial agents |
US20050014706A1 (en) * | 2003-07-14 | 2005-01-20 | Kanakeshwari Falzari | Method of treating tuberculosis |
WO2007069264A2 (en) * | 2005-12-15 | 2007-06-21 | Alembic Limited | Reference standards for determining the purity of telithromycin and processes therefor |
AU2008316830B2 (en) * | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
WO2010048600A1 (en) * | 2008-10-24 | 2010-04-29 | Cempra Pharmaceuticals, Inc. | Methods for treating resistant diseases using triazole containing macrolides |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
ES2608285T3 (es) | 2009-09-10 | 2017-04-07 | Cempra Pharmaceuticals, Inc. | Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC |
RU2650883C2 (ru) | 2010-03-22 | 2018-04-18 | Семпра Фармасьютикалз, Инк. | Кристаллические формы макролида и их применение |
PL2571506T3 (pl) | 2010-05-20 | 2017-10-31 | Cempra Pharmaceuticals Inc | Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich |
KR20180110181A (ko) | 2010-09-10 | 2018-10-08 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
MX2014011537A (es) | 2012-03-27 | 2015-02-10 | Cempra Pharmaceuticals Inc | Formulaciones parenterales para la administracion de antibioticos macrolidos. |
EP2968801B1 (en) | 2013-03-14 | 2018-09-26 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
AU2014233240B2 (en) | 2013-03-15 | 2018-08-09 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US487411A (en) * | 1892-12-06 | Island | ||
IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
US5444031A (en) * | 1993-01-21 | 1995-08-22 | Calgon Carbon Corporation | Process for making catalytic carbon |
FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
1996
- 1996-02-28 FR FR9602472A patent/FR2745290B1/fr not_active Expired - Lifetime
-
1997
- 1997-02-25 AR ARP970100760A patent/AR005999A1/es unknown
- 1997-02-26 ZA ZA9701659A patent/ZA971659B/xx unknown
- 1997-02-27 US US09/125,959 patent/US6096714A/en not_active Ceased
- 1997-02-27 WO PCT/FR1997/000351 patent/WO1997031929A1/fr active IP Right Grant
- 1997-02-27 UA UA98095031A patent/UA58504C2/uk unknown
- 1997-02-27 CZ CZ19982587A patent/CZ293893B6/cs not_active IP Right Cessation
- 1997-02-27 EE EE9800265A patent/EE9800265A/xx unknown
- 1997-02-27 AT AT97907141T patent/ATE217633T1/de active
- 1997-02-27 SK SK1184-98A patent/SK118498A3/sk unknown
- 1997-02-27 PL PL328608A patent/PL191736B1/pl unknown
- 1997-02-27 DK DK97907141T patent/DK0885234T3/da active
- 1997-02-27 ES ES97907141T patent/ES2176698T3/es not_active Expired - Lifetime
- 1997-02-27 HU HU9902576A patent/HU227567B1/hu unknown
- 1997-02-27 AP APAP/P/1998/001318A patent/AP952A/en active
- 1997-02-27 BR BRPI9707709-7A patent/BR9707709B1/pt not_active IP Right Cessation
- 1997-02-27 PT PT97907141T patent/PT885234E/pt unknown
- 1997-02-27 EA EA199800768A patent/EA001376B1/ru not_active IP Right Cessation
- 1997-02-27 AU AU19298/97A patent/AU716204B2/en not_active Expired
- 1997-02-27 KR KR10-1998-0706733A patent/KR100486053B1/ko not_active IP Right Cessation
- 1997-02-27 JP JP53067197A patent/JP4102440B2/ja not_active Expired - Lifetime
- 1997-02-27 EP EP97907141A patent/EP0885234B1/fr not_active Expired - Lifetime
- 1997-02-27 DE DE69712610T patent/DE69712610T2/de not_active Expired - Lifetime
- 1997-02-27 NZ NZ331600A patent/NZ331600A/xx unknown
- 1997-02-27 IL IL12562297A patent/IL125622A/xx not_active IP Right Cessation
- 1997-02-27 CN CNB971926255A patent/CN1168734C/zh not_active Expired - Lifetime
- 1997-02-27 TR TR1998/01713T patent/TR199801713T2/xx unknown
-
1998
- 1998-08-12 BG BG102691A patent/BG63207B1/bg unknown
- 1998-08-27 NO NO983955A patent/NO983955L/no not_active Application Discontinuation
- 1998-08-28 OA OA9800150A patent/OA10845A/fr unknown
- 1998-08-28 YU YU37098A patent/YU37098A/sh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2176698T3 (es) | Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. | |
ES2122472T3 (es) | Derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. | |
DE69903988D1 (de) | Fungizide Trifluorophenyltriazolopyrimidine | |
FI93831B (fi) | Tetratsolit, jotka ovat verenpainetta alentavien yhdisteiden välituotteita | |
DE60015927D1 (en) | Phenylharnstoff und phenylthioharnstoffderivate | |
PT1109812E (pt) | Pirrolobenzodiazepinas | |
DE59709414D1 (de) | Oxyiminopregnancarbolactone | |
IL123293A0 (en) | Piperidine derivatives their preparation and use | |
MX9602837A (es) | Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados. | |
GR3036714T3 (en) | Fungicidal trifluorophenyl-triazolopyrimidines | |
FI970417A (fi) | Aryylitioyhdisteet bakteerien ja virusten vastaisina aineina | |
DE60228071D1 (de) | Spiropyrazol-verbindungen | |
DK0923554T3 (da) | N-Benzylpiperidin- og tetrahydropyridinderivater | |
NO20004978D0 (no) | Semi-syntetiske ecteinascidiner | |
NO20014756D0 (no) | C(10)-heterosubstituerte acetattaksaner som antitmormidler | |
ATE289810T1 (de) | Ecteinascidinderivate | |
FI891283A0 (fi) | Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning. | |
ES2190429T3 (es) | Benciliden-quinuclidinonas como agentes protectores contra el sol. | |
ES2056153T3 (es) | Expectorante que comprende un derivado hidroxialquilcisteina. | |
ATE296623T1 (de) | Prolaktin-senkendes mittel | |
DK0660822T3 (da) | Cykliske benzylamino-, benzylamido- og benzylimidoderivater som antipsykotiske midler | |
ES2174323T3 (es) | Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. | |
ES2173556T3 (es) | Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen. | |
ES2063324T3 (es) | Derivados del acido butirico. | |
AR023374A1 (es) | Derivados de 3-amino-3-arilpropano-1-ol. su preparacion y uso |